Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer

World Journal of Urology

Volumn 24, Issue 3, 2006, Pages 289-295

  Machtens, Stefan ^a   Baumann, Rolf ^b   Hagemann, Jörn ^b   Warszawski, Antje ^b   Meyer, Andreas ^b   Karstens, Johann H ^b   Jonas, Udo ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Low dose rate brachytherapy; Morbidity; Prostate cancer; Seeds; Tumor control

Indexed keywords

ARTICLE; BRACHYTHERAPY; HUMAN; MALE; METHODOLOGY; MORTALITY; PROSTATE TUMOR; TREATMENT OUTCOME;

BRACHYTHERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 33746558061     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-006-0083-1     Document Type: Article

References (63)

1. Pasteau O (1911) Traitement du cancer de la prostate par le radium. Rev Mal Nutr 1911:363-367
2. Paschkis R (1911) Wien Klin Wochenschr 24:1562-1564
3. Barringer B (1917) Radium in the treatment of carcinoma of the bladder and prostate: Review of 1 year's work. JAMA 68:1227-1230
4. Flocks RH, Kerr HD, Elkins HB, Culp DA (1954) The treatment of carcinoma of the prostate by interstitial radiation with radioactive gold (Au198): a follow-up report. J Urol 71:628-633
5. Whitmore WF Jr, Hilaris B, Grabstald H (1972) Retropubic implantation of Iodine 125 in the treatment of prostate cancer. J Urol 108:918-920
6. Holm HH, Juul N, Pedersen JF, Hansen H, Stroyer I (1983) Transperineal 125 Iodine seed implantation in prostatic cancer guided by transrectal ultrasoundsonography. J Urol 130:283-2861
7. Ling CC (1992) Permanent implants using Au-198, Pd-103 and I-125: A radiobiological considerations based on the linear quadratic model. Int J Radiat Oncol Biol Phys 23:81-87
8. Nath R, Anderson LL, Luxton G (1995) Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group o.43. American Association of Physicists in Medicine. Med Phys 22:209-234
9. Beyer D, Nath R, Buller W (2000) American brachytherapy society recommendations for clinical implementation of NIST-1999 standards for (103) palladium brachytherapy. Int J Radiat Oncol Biol Phys 47:273-275
10. Williamson JF, Coursey BM, deWerd LA (2000) Recommendations of the American association of physicists in medicine on 103Pd interstitial source calibration and dosimetry: Implications for dose specification and prescription. Med Phys 27:634-642
11. Blasko JC, Wallner K, Grimm PD, Ragde H (1995) PSA-based disease control following ultrasound - guided 125J implantation for stage T1/T2 prostatic carcinoma. J Urol 154:1096-1099
12. Stock RG, Stone NN, Wesson MF, DeWyngaert JK (1995) A modified technique allowing interactive ultrasound - guided three - dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 32:219-225
13. Quimby EH (1932) The grouping of radium tubes in packs and plaques to produce the desired distribution of radiation. Am J Roentgenol 27:18-36
14. Paterson R, Parker HM (1943) A dosage system for gamma-ray therapy 1 + 2. Br J Radiol 7:592-632
15. Prete JJ, Prestidge BR, Bice WS, Friedland JL, Stock RG, Grimm PD (1998) A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys 40:1001-1008
16. Nag S, Bice W, DeWyngaert K, Prestidge B, Stock R, Yu Y (2000) American brachytherapy guidelines for post-implant dosimetry for prostate brachytherapy. Int J Radiat Oncol Biol Phys 46:221-230
17. Stock RG, Stone NN (2002) Importance of post-implant dosimetry in permanent brachytherapy. Eur Urol 41:434-439
18. Waterman FM, Yue N, Corn BW, Dicker AP (1998) Edema associated with I-125 or PD-103 prostate brachytherapy and its impact on post-implant dosimetry: An analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys 41:1069-1077
19. Stock RG, Stone NN, Tabert A, Ianuzzi C, DeWyngaert JK (1998) A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 41:101-108
20. Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L (2000) ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57:315-321
21. Wirth MP, Hermann T, Alken P, Kovacs G, Müller R-P, Hakenberg OW, Ahlemann L, Schalkhäuser K (2002) Empfehlungen zur Durchführung der alleinigen, permanenten, interstitiellen Brachytherapie beim lokal begrenzten Prostatakarzinom. Strahlenther Onkol 178:115-119
22. Grimm PD, Blasko JC, Sylvester JE (2001) 10 year biochemical (PSA) control of prostate cancer with Iodine-125 brachytherapy. Int J Radiat Biol Phys 51:31-40
23. Blasko JC, Grimm PD, Sylvester JE (2000) Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 46:839-850
24. Ragde H, Korb L, Elgamal AA (2000) A 12 year follow-up after transperineal brachytherapy of localized prostate cancer. J Urol 163(4, Suppl I):336-337
25. Brachman DG, Thomas T, Hilbe J, Beyer DC (2000) Failure-free survival following brachyherapy alone or external beam irridiation alone for T1-2 prostate tumors in 2222 patients: Results from a single practice. Int J Radiat Oncol Biol Phys 48:111-117
26. Grimm PD, Blasko JC, Sylvester JE (2001) 10 year biochemical (PSA) control of prostate cancer with Iodine-125 brachytherapy. Int J Radiat Biol Phys 51:31-40
27. Beyer DC, Thomas T, Hilbe J, Swenson V (2003) Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer. Brachytherapy 2(2):77-84
28. Potters L, Klein EA, Kattan MW, Reddy CA, Ciezki JP, Reuther AM, Kupelian PA (2004) Monotherapy for stage T1-T2 prostate cancer: Radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71(1):29-33
29. Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, Carlson TP, Klein EA (2004) Radical prostatectomy, external beam radiotherapy < 72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation and combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58(1):25-33
30. Sylvester JE, Blasko JC, Grimm R, Meier R, Spiegel JF, Malmgren JA (2004) Fifteen year follow-up of the first cohort of localized prostate cancer patients treated with brachytherapy. J Clin Oncol 22(145):4567
31. Potters C, Morgenstern C, Calugaru E, Fearn P, Jassal A, Presser J, Mullen E (2005) 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 173(5):1562-1566
32. Stone NN, Stock RG, Unger P (2005) Intermediate term biochemical-free progression andlocal control following 125 Iodine brachytherapy for prostate cancer. J Urol 173:803-807
33. Stone NN, Stock RG (1999) Prostate brachtherapy: Treatment strategies. J Urol 162:421-426
34. Sharkey J, Chovnick SD, Behar RD (2000) Minimally invasive treatment for localized adenocarcinoma of the prostate. Review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy. J Endourol 14:343-354
35. Potters L, Cha C, Oshinsky G (1999) Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy. Cancer J Sci Am 5:301-306
36. Sylvester J, Blasko JC, Grimm PD (2000) Short-course androgen ablation combined with external-beam radiation therapy and low-dose rate permanent brachytherapy in early-stage prostate cancer: A matched subset analysis. Mol Urol 3:155-160
37. Blasko JC, Ragde H, Grimm PD (1997) Potential for neoadjuvant hormonal therapy with brachytherapy for prostate cancer. Mol Urol 1:207-214
38. Wallner K, Blasko JC, Dattoli MJ (2001) Prostate brachytherapy made complicated. 2nd edn. Smart-Medicine Press, Seattle, WA
39. Blasko JC, Grim PD, Sylvester JE (2000) The role of external beam radiotherapy with J-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol 57:273-278
40. Arterbery VE, Wallner K, Roy J, Fuks Z (1993) Short-term morbidity from CT-planned transperineal 125J prostate implants. Int J Radiat Oncol Biol Phys 25:661-665
41. Zeitlin SI, Sherman J, Raboy A, Lederman G, Albert P (1998) High dose combination radiotherapy for the treatment of localized prostate cancer. J Urol 91:91-94
42. Vijverberg PLM, Blank LECM, Dabhoiwala NF, deReijke TM, Koedooder C (1993) Analysis of biopsy findings and implant quality following ultrasonically - guided 125-J implantation for localized prostatic carcinoma. Br J Urol 72:470-477
43. Gelblum DY, Potters L, Ashley R, Waldbaum R, Wang XH, Leibel S (1999) Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45:59-64
44. Merrick GS, Butler WM, Lief JH, Dorsey LT (2000) Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Biol Phys 47:121-125
45. Wallner KE, Roy J, Zelefsky M, Fuks Z, Harrison L (1995) Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal 125J prostate brachytherapy. Int J Radiat Oncol Biol Phys 32:465-471
46. Nag S, Scaperoth DD, Badalament R, Hall SA, Burgers J (1995) Transperineal palladium-103 prostate brachytherapy: Analysis of morbidity and seed migration. Urology 45:87-92
47. Storey MR, Landgren RC, Cottone JL (1999) Transperineal iodine-125 implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity. Int J Radiat Oncol Biol Phys 43:565-571
48. Talcott JA, Clark JC, Stark P (1999) Long-term treatment-related complications of brachytherapy for early prostate cancer: A survey of treated patients. Proc Annu Meet Am Soc Clin Oncol 18:1196-1205
49. Stock RG, Stone NN, Dalal M (2000) Patient reported long-term urinary morbidity and quality of life following 125J prostate brachytherapy. J Urol 163(4, Suppl I):1268
50. Stone NN, Stock RG (2002) Complications following permanent prostate brachytherapy. Eur Urol 41(4):427-433
51. Gelblum DY, Potters L (2000) Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 48(1):119-124
52. Snyder KM, Stock RG, Hong SM, Stone NN (2001) Defining the risk of developing grade 2 proctitis following 125J prostate brachytherapy using a rectal dose volume histogram analysis. Int J Radiat Oncol Biol Phys 50:335-341
53. Merrick GS, Butler WM, Dorsey AT, Lief JH, Walbert HL, Blatt HJ (1999) Rectal dosimetric analysis following prostate brachytherapy. Int J Radiat Oncol Biol Phys 43:1021-1027
54. Albert M, Tempany CM, Schultz D, Chen MH, Cormack RA, Kumar S (2003) Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer 98(5):949-954
55. Kaye KW, Olson DJ, Payne JT (1995) Detailed preliminary analysis of 125 iodine implantation for localized prostate cancer using percutaneous approach. J Urol 153:1020-1025
56. Critz FA, Tarlton RS, Holladay DA (1995) Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. Cancer 75:2383-2391
57. Grado GL, Larson TR, Balch CS (1998) Actuarial disease-free survival after prostate brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Int J Radiat Oncol Biol Phys 42:289-298
58. Zeitlin SI, Sherman J, Raboy A, Lederman G, Albert P (1998) High dose combination radiotherapy for the treatment of localized prostate cancer. J Urol 160:91-95
59. Kao J, Stock RG, Stone NN (2000) Long-term erectile function following real-time ultrasound-guided brachytherapy for prostate cancer. J Urol 163(4, Suppl I):1276
60. Dattoli M, Wallner KE, Cash JC (1996) 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys 35:875-879
61. Stock RG, Kao J, Stone NN (2001) Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 165:436-439
62. Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW (2001) Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 50(5):1235-1242
63. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Kurko BS, Lief JH, Allen ZA (2005) Erectile function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 62(2):437-447